Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1341, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PEG IFN- -2b plus ribavirin worth its cost in chronic hepatitis C
Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. :
Access to resources
Recommend
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 327, 2001-01 ,pp. :
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :
Amifostine worth extra cost in treating solid tumours
Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. :
Amifostine worth extra cost in treating solid tumours
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 306, 2001-01 ,pp. :